Is ALX Oncology Holdings Inc. (ALXO) a Buy, Sell, or Hold?
NASDAQ : ALXO
ALX Oncology Holdings Inc.
$2.07 USD
$0.04 (1.97%)
- Volume
- 27.28K
- Average Volume
- 1.39M
- Market Capitalization
- $278.55M
- P/E Ratio
- -1.21
- Dividend Yield
- 0.00%
- Price Target
- $4.00
- Year High
- $2.66
- Year Low
- $0.44
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.21
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
21
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
8
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$24909
ALXO Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
ALXO Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Wong Shelly | officer: SVP, FINANCE AND CAO | 2026-07-01 | S-Sale | 2.04 | 2026-07-06 |
| Knight Jeff E. | officer: Chief Dev & Operating Officer | 2026-04-16 | A-Award | 1.68 | 2026-04-17 |
| Klencke Barbara | officer: Chief Medical Officer | 2026-04-16 | A-Award | 1.68 | 2026-04-17 |
| Knight Jeff E. | 2026-04-13 | 0 | 2026-04-17 | ||
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | 2026-03-19 | S-Sale | 2.17 | 2026-03-23 |
| Pinto Shelly | officer: SVP, FINANCE AND CAO | 2026-03-19 | S-Sale | 2.17 | 2026-03-23 |
| Klencke Barbara | officer: Chief Medical Officer | 2026-03-03 | A-Award | 2.07 | 2026-03-05 |
| Klencke Barbara | officer: Chief Medical Officer | 2026-02-25 | 0 | 2026-03-05 | |
| Klencke Barbara | officer: Chief Medical Officer | 2026-02-25 | 1.65 | 2026-03-05 | |
| Klencke Barbara | officer: Chief Medical Officer | 2026-02-25 | 1.05 | 2026-03-05 | |
| Klencke Barbara | officer: Chief Medical Officer | 2026-02-25 | 1.48 | 2026-03-05 | |
| Pinto Shelly | officer: SVP, FINANCE AND CAO | 2026-02-18 | S-Sale | 2.27 | 2026-02-20 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | 2026-02-17 | F-InKind | 2.27 | 2026-02-19 |
| GOODMAN COREY S | director, 10 percent owner: | 2026-02-02 | P-Purchase | 1.57 | 2026-02-04 |
| Shantharam Harish | officer: Chief Financial Officer | 2026-01-26 | A-Award | 1.48 | 2026-01-28 |
| Pinto Shelly | officer: SVP, FINANCE AND CAO | 2026-01-26 | A-Award | 1.48 | 2026-01-28 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | 2026-01-26 | A-Award | 1.48 | 2026-01-28 |
| GOODMAN COREY S | director, 10 percent owner: | 2026-01-20 | A-Award | 1.32 | 2026-01-21 |
| Garland J. Scott | director | 2026-01-20 | A-Award | 1.32 | 2026-01-21 |
| Sandler Alan B. | director | 2026-01-20 | A-Award | 1.32 | 2026-01-21 |
| Curran Daniel J. | director | 2026-01-20 | A-Award | 1.32 | 2026-01-21 |
| Takimoto Chris H | director | 2026-01-20 | A-Award | 1.32 | 2026-01-21 |
| Hemrajani Rekha | director | 2026-01-20 | A-Award | 1.32 | 2026-01-21 |
| Pinto Shelly | officer: SVP, FINANCE AND CAO | 2026-01-06 | S-Sale | 1.11 | 2026-01-07 |
| Pinto Shelly | officer: SVP, FINANCE AND CAO | 2025-10-14 | A-Award | 1.7 | 2025-10-16 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | 2025-10-14 | A-Award | 1.7 | 2025-10-16 |
| Shantharam Harish | officer: Chief Financial Officer | 2025-10-14 | A-Award | 1.7 | 2025-10-16 |
| Klencke Barbara | director | 2025-09-17 | A-Award | 1.05 | 2025-09-19 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | 2025-09-17 | P-Purchase | 1.0805 | 2025-09-18 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | 2025-09-16 | P-Purchase | 1.066 | 2025-09-18 |
| Shantharam Harish | officer: Chief Financial Officer | 2025-08-18 | P-Purchase | 0.7787 | 2025-08-20 |
| Pinto Shelly | officer: SVP, FINANCE AND CAO | 2025-08-15 | S-Sale | 0.6404 | 2025-08-19 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | 2025-08-15 | S-Sale | 0.6404 | 2025-08-19 |
| Curran Daniel J. | director | 2025-08-12 | A-Award | 0.615 | 2025-08-13 |
| Curran Daniel J. | 2025-08-12 | 0 | 2025-08-13 | ||
| Pinto Shelly | officer: SVP, FINANCE AND CAO | 2025-07-07 | S-Sale | 0.4501 | 2025-07-08 |
| Pinto Shelly | officer: SVP, FINANCE AND CAO | 2025-06-30 | S-Sale | 0.43 | 2025-07-01 |
| Pinto Shelly | officer: SVP, FINANCE AND CAO | 2025-04-11 | A-Award | 0.49 | 2025-04-15 |
| Sandler Alan B. | officer: Chief Medical Officer | 2025-04-11 | A-Award | 0.49 | 2025-04-15 |
| Shantharam Harish | officer: Chief Financial Officer | 2025-04-11 | A-Award | 0.49 | 2025-04-15 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | 2025-04-11 | A-Award | 0.49 | 2025-04-15 |
| Pinto Shelly | officer: SVP, FINANCE AND CAO | 2025-03-14 | A-Award | 0 | 2025-03-18 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | 2025-03-14 | A-Award | 0 | 2025-03-18 |
| Pinto Shelly | officer: SVP, FINANCE AND CAO | 2025-02-19 | S-Sale | 1.1502 | 2025-02-21 |
| Pons Jaume | officer: PRESIDENT & CSO | 2025-02-19 | S-Sale | 1.1502 | 2025-02-21 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | 2025-02-19 | S-Sale | 1.1502 | 2025-02-21 |
| Hemrajani Rekha | director | 2025-01-21 | A-Award | 1.65 | 2025-01-23 |
| Garland J. Scott | director | 2025-01-21 | A-Award | 1.65 | 2025-01-23 |
| GOODMAN COREY S | director, 10 percent owner: | 2025-01-21 | A-Award | 1.65 | 2025-01-23 |
| Takimoto Chris H | director | 2025-01-21 | A-Award | 1.65 | 2025-01-23 |
| Takimoto Chris H | 2025-01-21 | 0 | 2025-01-23 | ||
| Klencke Barbara | director | 2025-01-21 | A-Award | 1.65 | 2025-01-23 |
| Klencke Barbara | director | 2025-01-21 | 0 | 2025-01-23 | |
| Shantharam Harish | officer: Chief Financial Officer | 2025-01-21 | A-Award | 1.65 | 2025-01-23 |
| Shantharam Harish | 2025-01-21 | 0 | 2025-01-23 | ||
| Pinto Shelly | officer: SVP, FINANCE AND CAO | 2025-01-21 | A-Award | 1.65 | 2025-01-23 |
| Sandler Alan B. | officer: Chief Medical Officer | 2025-01-21 | A-Award | 1.65 | 2025-01-23 |
| Pons Jaume | officer: PRESIDENT & CSO | 2025-01-21 | A-Award | 1.65 | 2025-01-23 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | 2025-01-21 | A-Award | 1.65 | 2025-01-23 |
| Pinto Shelly | officer: Interim CFO | 2025-01-06 | S-Sale | 1.8 | 2025-01-08 |
| Pinto Shelly | officer: Interim CFO | 2024-12-30 | S-Sale | 1.5802 | 2025-01-02 |
| Pons Jaume | officer: PRESIDENT & CSO | 2024-12-30 | S-Sale | 1.5802 | 2025-01-02 |
| Hemrajani Rekha | director | 2024-12-02 | P-Purchase | 1.5468 | 2024-12-04 |
| Pinto Shelly | officer: Interim CFO | 2024-12-02 | A-Award | 1.66 | 2024-12-04 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | 2024-12-02 | A-Award | 1.66 | 2024-12-04 |
| Sandler Alan B. | officer: Chief Medical Officer | 2024-11-18 | A-Award | 1.22 | 2024-11-19 |
| Pinto Shelly | officer: SVP, FINANCE AND CAO | 2024-08-14 | S-Sale | 2.58 | 2024-08-16 |
| Randolph Sophia | officer: CHIEF MEDICAL OFFICER | 2024-08-14 | S-Sale | 2.58 | 2024-08-16 |
| GARCIA PETER S | officer: CHIEF FINANCIAL OFFICER | 2024-08-14 | F-InKind | 2.58 | 2024-08-16 |
| Pons Jaume | officer: PRESIDENT & CSO | 2024-08-14 | S-Sale | 2.58 | 2024-08-16 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | 2024-08-14 | F-InKind | 2.58 | 2024-08-16 |
| Sandler Alan B. | director | 2024-08-05 | A-Award | 2.73 | 2024-08-07 |
| Sandler Alan B. | 2024-08-05 | 0 | 2024-08-07 | ||
| Pons Jaume | director, officer: PRESIDENT & CSO | 2024-07-11 | M-Exempt | 0.99 | 2024-07-15 |
| Pons Jaume | director, officer: PRESIDENT & CSO | 2024-07-11 | S-Sale | 7.9038 | 2024-07-15 |
| Pons Jaume | director, officer: PRESIDENT & CSO | 2024-07-11 | M-Exempt | 0.99 | 2024-07-15 |
| Pinto Shelly | officer: SVP, FINANCE AND CAO | 2024-07-05 | S-Sale | 5.4993 | 2024-07-09 |
| Pinto Shelly | officer: SVP, FINANCE AND CAO | 2024-07-01 | S-Sale | 5.8188 | 2024-07-03 |
| Randolph Sophia | director, officer: CHIEF MEDICAL OFFICER | 2024-07-01 | S-Sale | 5.8188 | 2024-07-03 |
| Pons Jaume | director, officer: PRESIDENT & CSO | 2024-07-01 | S-Sale | 5.8188 | 2024-07-03 |
| GARCIA PETER S | officer: CHIEF FINANCIAL OFFICER | 2024-06-28 | F-InKind | 6.03 | 2024-07-02 |
| GARCIA PETER S | officer: CHIEF FINANCIAL OFFICER | 2024-06-13 | P-Purchase | 8.5282 | 2024-06-17 |
| Hemrajani Rekha | director | 2024-06-13 | A-Award | 8.44 | 2024-06-14 |
| Garland J. Scott | director | 2024-06-13 | A-Award | 8.44 | 2024-06-14 |
| GOODMAN COREY S | director, 10 percent owner: | 2024-06-13 | A-Award | 8.44 | 2024-06-14 |
| Pons Jaume | director, officer: PRESIDENT & CSO | 2024-06-04 | M-Exempt | 0.99 | 2024-06-06 |
| Pons Jaume | director, officer: PRESIDENT & CSO | 2024-06-04 | S-Sale | 8.4326 | 2024-06-06 |
| Pons Jaume | director, officer: PRESIDENT & CSO | 2024-06-04 | M-Exempt | 0.99 | 2024-06-06 |
| Randolph Sophia | director, officer: CHIEF MEDICAL OFFICER | 2024-05-13 | S-Sale | 15.8169 | 2024-05-15 |
| Randolph Sophia | director, officer: CHIEF MEDICAL OFFICER | 2024-05-13 | S-Sale | 16.6716 | 2024-05-15 |
| Pons Jaume | director, officer: PRESIDENT & CSO | 2024-05-06 | M-Exempt | 0.99 | 2024-05-08 |
| Pons Jaume | director, officer: PRESIDENT & CSO | 2024-05-06 | S-Sale | 15.9167 | 2024-05-08 |
| Pons Jaume | director, officer: PRESIDENT & CSO | 2024-05-06 | M-Exempt | 0.99 | 2024-05-08 |
| Pons Jaume | director, officer: PRESIDENT & CSO | 2024-04-16 | M-Exempt | 0.99 | 2024-04-18 |
| Pons Jaume | director, officer: PRESIDENT & CSO | 2024-04-16 | S-Sale | 14.2039 | 2024-04-18 |
| Pons Jaume | director, officer: PRESIDENT & CSO | 2024-04-16 | M-Exempt | 0.99 | 2024-04-18 |
| Pons Jaume | director, officer: PRESIDENT & CSO | 2024-04-04 | S-Sale | 11.1518 | 2024-04-05 |
| Lettmann Jason | director, officer: CHIEF EXECUTIVE OFFICER | 2024-03-14 | P-Purchase | 11.3117 | 2024-03-18 |
| Pinto Shelly | officer: SVP, FINANCE AND CAO | 2024-02-14 | A-Award | 0 | 2024-02-16 |
| Pinto Shelly | officer: SVP, FINANCE AND CAO | 2024-02-14 | A-Award | 15.84 | 2024-02-16 |